Global Coagulation Testing Market - Forecasts From 2018 to 2023
The global coagulation testing market is projected to grow at a CAGR of 7.65%, increasing from US$1,955.420 million in 2017 to US$3,042.760 million in 2023. Coagulation is the blood’s ability to clot and prevent excessive bleeding. Coagulation testing refers to the measure of blood’s ability to clot, and the time it takes to clot. Clotting disorders can cause excessive bleeding or may lead to clot formation and can be fatal in either of the two scenario. Thus, coagulation tests are done to assess the blood clotting function in patients. The global coagulation testing market is expected to witnessing significant growth during the giving forecast period owing to the rising prevalence of the blood disorders. Development of high-sensitivity POC coagulation testing techniques will also augment the coagulation testing market during the given forecast period. However, high cost of the instruments coupled with the dearth of skilled work force might restrain the market for coagulation testing during the given time frame.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global coagulation testing market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global coagulation testing market.
Major industry players profiled as part of the report are Diagnostica Stago, S.A.S., Sekisui Medical Co., Ltd. and Tcoag Ireland Ltd. among others.
Segmentation
By Test Type
Prothrombin Time Testing
Fibrinogen Testing
Activated Clotting Time Testing
Platelet Function Tests
Other
By End Users
Hospitals and Clinics
Diagnostic Centres
Ambulatory Care Centres
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global coagulation testing market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global coagulation testing market.
Major industry players profiled as part of the report are Diagnostica Stago, S.A.S., Sekisui Medical Co., Ltd. and Tcoag Ireland Ltd. among others.
Segmentation
By Test Type
Prothrombin Time Testing
Fibrinogen Testing
Activated Clotting Time Testing
Platelet Function Tests
Other
By End Users
Hospitals and Clinics
Diagnostic Centres
Ambulatory Care Centres
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL COAGULATION TESTING MARKET FORECAST BY TEST TYPE
5.1. Prothrombin Time Testing
5.2. Fibrinogen Testing
5.3. Activated Clotting Time Testing
5.4. Platelet Function Tests
5.5. Other
6. GLOBAL COAGULATION TESTING MARKET FORECAST BY END USERS
6.1. Hospitals and Clinics
6.2. Diagnostic Centres
6.3. Ambulatory Care Centres
7. GLOBAL COAGULATION TESTING MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
7.1. North America
7.1.1. The U.S
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. U.K.
7.3.2. France
7.3.3. Germany
7.3.4. Italy
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. UAE
7.4.3. Israel
7.4.4. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. India
7.5.3. Australia
7.5.4. South Korea
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Market Share Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals
9. COMPANY PROFILES
9.1. Abbott
9.1.1. Overview
9.1.2. Financials
9.1.3. Product and Services
9.1.4. Recent Developments
9.2. Diagnostica Stago, S.A.S.
9.2.1. Overview
9.2.2. Financials
9.2.3. Product and Services
9.2.4. Recent Developments
9.3. Roche Diagnostics
9.3.1. Overview
9.3.2. Financials
9.3.3. Product and Services
9.3.4. Recent Developments
9.4. Thermo Fisher Scientific
9.4.1. Overview
9.4.2. Financials
9.4.3. Product and Services
9.4.4. Recent Developments
9.5. r² Diagnostics
9.5.1. Overview
9.5.2. Financials
9.5.3. Product and Services
9.5.4. Recent Developments
9.6. Sekisui Medical Co., Ltd.
9.6.1. Overview
9.6.2. Financials
9.6.3. Product and Services
9.6.4. Recent Developments
9.7. Tcoag Ireland Ltd.
9.7.1. Overview
9.7.2. Financials
9.7.3. Product and Services
9.7.4. Recent Developments
9.8. Coagulation Sciences LLC
9.8.1. Overview
9.8.2. Financials
9.8.3. Product and Services
9.8.4. Recent Developments
9.9. RUSNANO Group
9.9.1. Overview
9.9.2. Financials
9.9.3. Product and Services
9.9.4. Recent Developments
9.10. Universal Biosensors
9.10.1. Overview
9.10.2. Financials
9.10.3. Product and Services
9.10.4. Recent Developments
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL COAGULATION TESTING MARKET FORECAST BY TEST TYPE
5.1. Prothrombin Time Testing
5.2. Fibrinogen Testing
5.3. Activated Clotting Time Testing
5.4. Platelet Function Tests
5.5. Other
6. GLOBAL COAGULATION TESTING MARKET FORECAST BY END USERS
6.1. Hospitals and Clinics
6.2. Diagnostic Centres
6.3. Ambulatory Care Centres
7. GLOBAL COAGULATION TESTING MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
7.1. North America
7.1.1. The U.S
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. U.K.
7.3.2. France
7.3.3. Germany
7.3.4. Italy
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. UAE
7.4.3. Israel
7.4.4. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. India
7.5.3. Australia
7.5.4. South Korea
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Market Share Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals
9. COMPANY PROFILES
9.1. Abbott
9.1.1. Overview
9.1.2. Financials
9.1.3. Product and Services
9.1.4. Recent Developments
9.2. Diagnostica Stago, S.A.S.
9.2.1. Overview
9.2.2. Financials
9.2.3. Product and Services
9.2.4. Recent Developments
9.3. Roche Diagnostics
9.3.1. Overview
9.3.2. Financials
9.3.3. Product and Services
9.3.4. Recent Developments
9.4. Thermo Fisher Scientific
9.4.1. Overview
9.4.2. Financials
9.4.3. Product and Services
9.4.4. Recent Developments
9.5. r² Diagnostics
9.5.1. Overview
9.5.2. Financials
9.5.3. Product and Services
9.5.4. Recent Developments
9.6. Sekisui Medical Co., Ltd.
9.6.1. Overview
9.6.2. Financials
9.6.3. Product and Services
9.6.4. Recent Developments
9.7. Tcoag Ireland Ltd.
9.7.1. Overview
9.7.2. Financials
9.7.3. Product and Services
9.7.4. Recent Developments
9.8. Coagulation Sciences LLC
9.8.1. Overview
9.8.2. Financials
9.8.3. Product and Services
9.8.4. Recent Developments
9.9. RUSNANO Group
9.9.1. Overview
9.9.2. Financials
9.9.3. Product and Services
9.9.4. Recent Developments
9.10. Universal Biosensors
9.10.1. Overview
9.10.2. Financials
9.10.3. Product and Services
9.10.4. Recent Developments
